These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 822764)

  • 1. Maintenance of therapeutic phenytoin plasma levels via intramuscular administration.
    Perrier D; Rapp R; Young B; Kostenbauder H; Cady W; Pancorbo S; Hackman J
    Ann Intern Med; 1976 Sep; 85(3):318-21. PubMed ID: 822764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early post-traumatic epilepsy prophylaxis.
    Young B; Rapp RP; Perrier D; Kostenbauder H; Hackman J; Blacker HM
    Surg Neurol; 1975 Sep; 4(3):339-42. PubMed ID: 809855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttraumatic epilepsy prophylaxis.
    Young B; Rapp R; Brooks WH; Madauss W; Norton JA
    Epilepsia; 1979 Dec; 20(6):671-81. PubMed ID: 115679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An effective dose schedule for phenytoin treatment of status epilepticus in infancy and childhood.
    Albani M
    Neuropadiatrie; 1977 Aug; 8(3):286-92. PubMed ID: 578299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and intramuscular phenytoin.
    Wilder BJ; Ramsay RE
    Clin Pharmacol Ther; 1976 Mar; 19(3):360-4. PubMed ID: 770051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.
    Kostenbauder HB; Rapp RP; McGovren JP; Foster TS; Perrier DG; Blacker HM; Hulon WC; Kinkel AW
    Clin Pharmacol Ther; 1975 Oct; 18(4):449-56. PubMed ID: 1100308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric use of intravenous and intramuscular phenytoin: lessons learned.
    Wheless JW
    J Child Neurol; 1998 Oct; 13 Suppl 1():S11-4; discussion S30-2. PubMed ID: 9796746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
    Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
    Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acute phase response on phenytoin metabolism in neurotrauma patients.
    McKindley DS; Boucher BA; Hess MM; Rodman JH; Feler C; Fabian TC
    J Clin Pharmacol; 1997 Feb; 37(2):129-39. PubMed ID: 9055139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of parenteral diphenylhydantoin therapy of status epilepticus from the years 1959-1965].
    Pilz C; Dreyer R
    Arch Psychiatr Nervenkr (1970); 1969; 212(3):254-70. PubMed ID: 4981258
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum level determination in patients with acute myocardial infarction under diphenylhydantoin therapy].
    Kettner W; Quednow B; Wilckens H; Walther H
    Z Gesamte Inn Med; 1979 Oct; 34(20):suppl 282-4. PubMed ID: 549293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of maintenance phenytoin therapy after intravenous loading dose.
    Riviello JJ; Roe EJ; Sapin JI; Grover WD
    Pediatr Neurol; 1991; 7(4):262-5. PubMed ID: 1930417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of unbound phenytoin serum levels in head trauma patients.
    Bauer LA; Edwards WA; Dellinger EP; Raisys VA; Brennan C
    J Trauma; 1983 Dec; 23(12):1058-60. PubMed ID: 6418891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of late post-traumatic epilepsy by phenytoin in severe brain injuries. 2 years' follow-up].
    Pechadre JC; Lauxerois M; Colnet G; Commun C; Dimicoli C; Bonnard M; Gibert J; Chabannes J
    Presse Med; 1991 May; 20(18):841-5. PubMed ID: 1829177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular use of fosphenytoin: an overview.
    Uthman BM; Wilder BJ; Ramsay RE
    Neurology; 1996 Jun; 46(6 Suppl 1):S24-8. PubMed ID: 8649611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin.
    Serrano EE; Roye DB; Hammer RH; Wilder BJ
    Neurology; 1973 Mar; 23(3):311-7. PubMed ID: 4735181
    [No Abstract]   [Full Text] [Related]  

  • 17. Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis.
    McQueen JK; Blackwood DH; Harris P; Kalbag RM; Johnson AL
    J Neurol Neurosurg Psychiatry; 1983 Oct; 46(10):899-904. PubMed ID: 6417279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of prophylactically administered phenytoin to prevent post-traumatic seizures in children.
    Young B; Rapp RP; Norton JA; Haack D; Walsh JW
    Childs Brain; 1983; 10(3):185-92. PubMed ID: 6409521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.
    Knapp LE; Kugler AR
    J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma concentrations after injection or infusion of phenytoin (author's transl)].
    Schmidt D; Vogel A
    Klin Wochenschr; 1977 Mar; 55(5):219-23. PubMed ID: 846182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.